Lena Illert

Prof. Lena Illert is a Professor of Personalized Oncology at the Technical University of Munich (TUM) and Medical Director of the Center for Personalized Medicine (ZPM) at the Klinikum rechts der Isar. She leads the TUM Translational Molecular Tumor Board, focusing on personalized therapy recommendations for oncology patients through interdisciplinary collaboration. Her expertise spans translational oncology, target structure identification, and biomarker validation for immune and molecular treatments.

• Education:
• Studied medicine at the University of Göttingen
• Doctorate at the Institute of Biochemistry
• Specialist training in internal medicine, hematology/oncology, and palliative medicine at TUM and University Hospital Freiburg
• Key Career Steps:
• Habilitation completed
• Residency at the Medical Center Freiburg (MSKCC)
• Co-Director of the CCC Freiburg and Managing Senior Physician
• Appointed to TUM in 2023

Her research emphasizes integrating genomic and clinical data to tailor cancer therapies. Recent work highlights advancements in molecular tumor boards, rare cancer analysis, and stem cell biology. Awards include the Mildred Scheel Professorship (2023) and the Mathilde Wagner Habilitation Prize (2015).

• Awards:
• Mildred Scheel Professorship (2023)
• Advanced Clinician Scientist Fellowship (2021)
• Brigitte Schlieben-Langen Scholarship (2018)

Her leadership encompasses directing the ZPM and advancing translational research through collaborative networks. Ongoing efforts focus on bridging basic science and clinical application to enhance patient outcomes.